BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 16275620)

  • 1. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
    Chen Y; Wei H; Sun R; Tian Z
    Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice.
    Ochi M; Ohdan H; Mitsuta H; Onoe T; Tokita D; Hara H; Ishiyama K; Zhou W; Tanaka Y; Asahara T
    Hepatology; 2004 May; 39(5):1321-31. PubMed ID: 15122761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
    J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis.
    Pan HN; Sun R; Jaruga B; Hong F; Kim WH; Gao B
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1615-23. PubMed ID: 16930225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.
    Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA
    J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The functions of liver natural killer cells in murine fulminant hepatitis induced by murine hepatitis virus strain 3].
    Zou Y; Chen T; Wang HW; Yan WM; Luo XP; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):660-4. PubMed ID: 18822205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
    Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
    J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
    Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
    Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure.
    Zou Y; Chen T; Han M; Wang H; Yan W; Song G; Wu Z; Wang X; Zhu C; Luo X; Ning Q
    J Immunol; 2010 Jan; 184(1):466-75. PubMed ID: 19949088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of hepatic NK cell development in IFN-γ deficient mice.
    Wu X; Chen Y; Sun R; Wei H; Tian Z
    Cytokine; 2012 Dec; 60(3):616-25. PubMed ID: 22921904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dendritic cell subset involved in tumor immunosurveillance.
    Taieb J; Chaput N; Ménard C; Apetoh L; Ullrich E; Bonmort M; Péquignot M; Casares N; Terme M; Flament C; Opolon P; Lecluse Y; Métivier D; Tomasello E; Vivier E; Ghiringhelli F; Martin F; Klatzmann D; Poynard T; Tursz T; Raposo G; Yagita H; Ryffel B; Kroemer G; Zitvogel L
    Nat Med; 2006 Feb; 12(2):214-9. PubMed ID: 16444265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver.
    Manoussaka M; Georgiou A; Rossiter B; Shrestha S; Toomey JA; Sivakumar PV; Bennett M; Kumar V; Brooks CG
    J Immunol; 1997 Jan; 158(1):112-9. PubMed ID: 8977181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.